<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">AS</journal-id><journal-title-group><journal-title>Agricultural Sciences</journal-title></journal-title-group><issn pub-type="epub">2156-8553</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/as.2012.31001</article-id><article-id pub-id-type="publisher-id">AS-16854</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Earth&amp;Environmental Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Liver cytochrome P450 system as affected by endophyte-infected tall fescue seed extracts and ergot alkaloids
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>li</surname><given-names>S. Moubarak</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Zelpha</surname><given-names>B. Johnson</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Charles</surname><given-names>F. Rosenkrans Jr.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Animal Sciences, University of Arkansas, Fayetteville, USA</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>moubarak@uark.edu(LSM)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>01</month><year>2012</year></pub-date><volume>03</volume><issue>01</issue><fpage>1</fpage><lpage>4</lpage><history><date date-type="received"><day>25</day>	<month>September</month>	<year>2011</year></date><date date-type="rev-recd"><day>29</day>	<month>November</month>	<year>2011</year>	</date><date date-type="accepted"><day>20</day>	<month>December</month>	<year>2011</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Endophyte infected tall fescue (E+) is the base diet for nearly all beef cattle in the southern USA. It has been linked to a variety of toxicological conditions due to the presence of large numbers of ergot alkaloids. This study was designed to investigate the effects of E+ seed extract and selected ergot alkaloids on the detoxification pathway by cytochrome P450 (CYP3A4) enzyme system. Tests were performed using the P450- Glo CYP3A4 enzyme activity kit (Promega, WI), according to the manufacturer’s manual. Luminescence was measured using a single tube TD20/20 luminometer. Endophyte infected tall fescue seed was extracted with 50/50 methanol/25 mM ammonium carbonate, cleaned and concentrated on Strata-X reversed phase column (Phenomenex). The extracts were evaluated on an HPLC, and then tested using a serial dilution method. Commercially available ergonovine (EN), ergocorine (ER), bromocryptine (BC) and ergocryptine (EC) were tested individually using 0 to 44 nM concentrations. Seed extract of E+ produced a significant (
  P &lt; 0.05) dose dependent inhibition of CYP3A4 enzyme activity similar to that produced by the commercially available ergot alkaloids EC, ER, BC and EN which inhibited CYP3A4 enzyme activity in a significant (
  P &lt; 0.05) dose dependent manner with EC being most potent, followed by ER, BC, and then EN (70%, 40%, 30% and 10% at 44 nM concentration). The similarity of the inhibition curves of seed extract to that of the commercially available ergot alkaloids suggests a related mode of action and that the use of such ergot alkaloids and CYP3A4 assay is a good model to study the toxicity of tall fescue. Furthermore, it provides the foundation to identify the individual toxic components of purified endophyte infected tall fescue extract.
 
</p></abstract><kwd-group><kwd>Seed Extract; Tall Fescue; CYP3A4; Ergot Alkaloid</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. INTRODUCTION</title><p>Tall fescue grass is considered to be the primary diet for nearly all beef cattle in the southern United States and has been linked to the incidence of fescue toxicosis syndrome due to the presence of ergot alkaloids. Cytochrome P450 (CYP) enzyme systems play a key role in the biotransformation of many endogenous and exogenous compounds including both toxins and drugs [<xref ref-type="bibr" rid="scirp.16854-ref1">1</xref>] and [<xref ref-type="bibr" rid="scirp.16854-ref2">2</xref>]. The CYP enzyme family consists of a large number of proteins with different substrate specificities and catalytic properties which are membrane-bound, mostly localized to the endoplasmic reticulum and in mitochondrial inner membranes. Ergot alkaloids found in tall fescue are a large family of chemical compounds with two major subfamilies. These are the tetracyclic ergoline nucleus group, such as lysergic acid ethylamide, ergonovine, and lysergic acid, and the ergopeptide alkaloids group which share the tetracyclic ergoline nucleus in addition to tricyclic amino acids such as ergotamine, ergocryptine, and bromocriptine. The metabolism of ergot alkaloids, such as bromocryptine, dihydroergotamine, and other structurally similar ergot derivatives is mediated mainly by CYP3A4 [<xref ref-type="bibr" rid="scirp.16854-ref3">3</xref>]. Moochhala et al. (1989) [<xref ref-type="bibr" rid="scirp.16854-ref4">4</xref>] reported that bromocryptine interferes with P450-dependent oxidative metabolism of xenobiotics. Later it was demonstrated that cytochrome P450 3A exhibits a particularly high affinity for ergopeptides. Ergot alkaloids have been shown to be metabolized by CYP3A; however, information on the effects of these alkaloids on CYP3A activity is very limited. The metabolism of ergot alkaloids has been linked to CYP3A; therefore, activation or inhibition of the induction process of such enzyme systems can have severe consequences on the metabolism of the ergot alkaloids. Witkamp et al. (1995) [<xref ref-type="bibr" rid="scirp.16854-ref5">5</xref>] reported that tiamulin, a semi-synthetic antibiotic frequently used in agricultural animals, strongly inhibited the hydroxylation rate of testosterone at the 6 beta‑position via the formation of a cytochrome P450 3A4 metabolic intermediate complex in both microsomes and hepatocytes. We have reported previously [<xref ref-type="bibr" rid="scirp.16854-ref6">6</xref>] the lack of induction effects of dihydroergotamine and ergonovine on rat CYP3A. The endophyte-infected seed extract treatment was found to suppressed prolactin secretion and the endophyte-free seed extract treatment had no effect on prolactin secretion by rat anterior pituitaries [<xref ref-type="bibr" rid="scirp.16854-ref7">7</xref>]. This study was designed to examine the effects of seed extract of endophyte infected and non infected tall fescue and selected ergot alkaloids ergnovine (EN), ergocorine (ER), bromocryptine (BC) and ergocryptine (EC) on the detoxification pathway by cytochrome P450 (CYP3A4) enzyme system in vitro.</p></sec><sec id="s2"><title>2. MATERIALS AND METHODS</title><p>All the chemicals and reagents used in these experiments were of the highest quality available and were purchased from Sigma Chemical Co. (St. Louis, MO) unless stated otherwise. Tests were performed using the P450-Glo CYP3A4 enzyme activity kit (Promega, WI), according to the manufacturer’s manual. Luminescence was measured using a single tube TD20/20 illuminometer. Briefly, 12.5 &#181;l of test compound (seed extract or pure pushed ergot alkaloids) was added per well of a 96-well plate, followed by 12.5 &#181;l of the 4 times concentrated CYP450 reaction mixture with and without CYP450 for the blank reactions. Then the plate was pre-incubated at 37˚C for 10 minutes. The reaction was initiated by adding 25 &#181;l of the 2 times concentrated NADPH regeneration system and after 30 minutes incubation at 37˚C, 50 &#181;l of reconstituted luciferin detection reagent was added. The plate was mixed for 10 seconds on an orbital shaker and incubated at room temperature for 20 minutes to stabilize the luminescent signal. Then the luminescence was recorded using Perkin Elmer 1420 Victor 3 V.</p><p>Endophyte infected tall fescue seed (E+) was extracted with 50/50 methanol/25 mM ammonium carbonate (10 ml/gm) for one hour, cleaned and concentrated on Strata-X reversed phase column (Phenomenex). The extracts were evaluated by a Millennium<sup>32</sup> Workstation HPLC system with auto-sample injector and a gradient programmer. The detection was accomplished using an Applied Biosystems 980 programmable fluorescence detector (excitation at 250 nm and emission at 370 nm long pass filter).&#160; Separation was conducted on a 3 &#215; 3 CR C18 cartridge column using acetonitrile and 2.6 mM ammonium carbonate in 10% methanol gradient elution at 1 ml/min flow rate. The extracts were evaluated using 80% serial dilution method, and the commercially available EC, ER, BC and EN were tested individually using 0 to 44 nM concentrations.</p></sec><sec id="s3"><title>3. RESULTS AND DISCUSSION</title><p>The HPLC chromatogram in <xref ref-type="fig" rid="fig1">Figure 1</xref> shows the presence of number of ergot alkaloids in endophyte infected tall fescue. These compounds range from very hydrophilic to very hydrophobic. The non-infected tall fescue seed extract is lacking any of these ergot alkaloids. The toxins found in seed extract of endophyte infected tall fescue inhibited CYP3A4 enzyme activity (<xref ref-type="fig" rid="fig2">Figure 2</xref>) in an action similar to that of commercially available ergot alkaloids (EC, ER, and BC) (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Seed extract of E+ produced a (<xref ref-type="fig" rid="fig2">Figure 2</xref>) dose dependent inhibition (59 and 81% inhibition at 11 and 100% of extract concentrations, respectively (P &lt; 0.05) of CYP3A4 enzyme activity. Non-infected tall fescue seed extract (E–) produced no significant effect on CYP3A4 activity due to the lack of the toxins (Figures 1 and 2).</p><p>Ergocryptine, ER, and BC inhibited CYP3A4 enzyme activity in a significant (P &lt; 0.05) dose dependent manner with EC being most potent, followed by ER, and then BC (70%, 40%, and 30% at 44 nM concentration) (<xref ref-type="fig" rid="fig3">Figure 3</xref>). The EN effect was not significant. The similarity of the inhibition curves and the chemical structure of toxins found in seed extract to that of the commercially available ergot alkaloids suggest that the toxins found in E+ appear to target the same location on the CYP3A4 and follow the same mechanism of inhibition. The connection between the effects of fescue toxins and the effects of the single ergot alkaloids, EC, ER, BC and EN, on CYP enzyme systems has been established. Such association helps in understanding of the effects of E+ in general and lays the foundation to study the detailed effects of each single component of fescue toxins on liver detoxification mechanisms. Also the use of P450-Glo CYP3A4 enzyme activity kit appeared to be a good instrument to study and identify the toxic individual components of purified endophyte infected tall fescue extract.</p></sec><sec id="s4"><title>REFERENCES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.16854-ref1"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Porter</surname><given-names> T.D. and Coon</given-names></name>,<name name-style="western"><surname> M.J. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1991</year>)<article-title>Cytochrome P-450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms</article-title><source> Journal of Biological Chemistry</source><volume> 266</volume>,<fpage> 13469</fpage>-<lpage>13472</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.16854-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Pollock, B.G. (1994) Recent developments in drug metabolism of relevance to psychiatrists. Harvard Review of Psychiatry, 2, 204-213.  
doi:10.3109/10673229409017138</mixed-citation></ref><ref id="scirp.16854-ref3"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ball</surname><given-names> S.E.</given-names></name>,<name name-style="western"><surname> Maurer</surname><given-names> G.</given-names></name>,<name name-style="western"><surname> Zollinger</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> Ladona</surname><given-names> M. and Vicker</given-names></name>,<name name-style="western"><surname> A.E. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1992</year>)<article-title>Characterization of the cytochrome P-450 gene family responsible for the N-dealkylation of the ergot alkaloid CQA 206-291 in humans</article-title><source> Drug Metabolism and Disposition</source><volume> 20</volume>,<fpage> 56</fpage>-<lpage>63</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.16854-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Moochhala, S.M., Lee, E.J., Hu, G.T., Koh, O.S. and Becket, G. (1989) Effects of bromocryptine on hepatic cytochrome P-450 monooxygenase system. Japanese Journal of Pharmacology, 49, 285-291.  
doi:10.1254/jjp.49.285</mixed-citation></ref><ref id="scirp.16854-ref5"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Witkamp</surname><given-names> R.F.</given-names></name>,<name name-style="western"><surname> Nijmeijer</surname><given-names> S.M.</given-names></name>,<name name-style="western"><surname> Monshouwer</surname><given-names> M. and Van Miert</given-names></name>,<name name-style="western"><surname> A.S. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1995</year>)<article-title>The antibiotic tiamulin is a potent inducer and inhibitor of cytochrome P4503A via the formation of a stable metabolic intermediate complex. Studies in primary hepatocyte cultures and liver microsomes of the pig</article-title><source> Drug Metabolism and Disposition</source><volume> 23</volume>,<fpage> 542</fpage>-<lpage> 547</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.16854-ref6"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moubarak A.S.</surname><given-names> Rosenkrans</given-names></name>,<name name-style="western"><surname> C.F. Jr. and Johnson</surname><given-names> Z.B. </given-names></name>,<etal>et al</etal>. (<year>2003</year>)<article-title>Modulation of Cytochrome P450 Metabolism by Ergonovine and Dihydroergotamine</article-title><source> Veterinary &amp; Human Toxicology</source><volume> 45</volume>,<fpage> 6</fpage>-<lpage>9</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.16854-ref7"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Strickland</surname><given-names> J.R</given-names></name>,<name name-style="western"><surname> Cross</surname><given-names> D.L</given-names></name>,<name name-style="western"><surname> Jenkins</surname><given-names> T.C.</given-names></name>,<name name-style="western"><surname> Petroski</surname><given-names> R.J. and Powell</given-names></name>,<name name-style="western"><surname> R.G </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1992</year>)<article-title>The effect of alkaloids and seed extracts of endophyte-infected tall fescue on prolactin secretion in an in vitro rat pituitary perfusion system</article-title><source> Journal of Animal Science</source><volume> 70</volume>,<fpage> 2779</fpage>-<lpage>2786</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref></ref-list></back></article>